Akanda (AKAN) Notes Payables (2022 - 2025)

Akanda's (AKAN) quarterly Notes Payables came in at $1.0 million in Q4 2025, up 185.4% year-on-year from $352814.0 in Q4 2024, and up 185.4% quarter-over-quarter from $352814.0 in Q4 2024.

Akanda (AKAN) Notes Payables (2022 - 2025) Analysis & Trends

Akanda's Notes Payables history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2025.

  • On a quarterly basis, Notes Payables rose 185.4% year-over-year to $1.0 million in Q4 2025; TTM through Dec 2025 was $1.0 million, a 185.4% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 185.4% from the prior year.
  • Notes Payables climbed to $1.0 million in Q4 2025 per AKAN's latest filing, from $352814.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.0 million in Q4 2025 and bottomed at $352814.0 in Q4 2024.
  • The 4-year median for Notes Payables is $905904.5 (2022), against an average of $792885.8.
  • Across the five-year window, Notes Payables slumped 59.68% in 2024 and jumped 185.4% in 2025, its largest moves.
  • Year by year, Notes Payables stood at $936793.0 in 2022, then retreated by 6.59% to $875016.0 in 2023, then slumped by 59.68% to $352814.0 in 2024, then surged by 185.4% to $1.0 million in 2025.
  • Per Business Quant, the three latest AKAN Notes Payables figures stand at $1.0 million (Q4 2025), $352814.0 (Q4 2024), and $875016.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Akanda 556,353.85 556,353.85 -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.01 Mn
Dec 31, 2024 352,814.00
Dec 31, 2023 875,016.00
Dec 31, 2022 936,793.00